Pharmacy Plus, Inc. dba Vital Care Compounder: Drug Recall

Recall #D-0049-2023 · 10/07/2022

Class II: Risk

Recall Details

Recall Number: D-0049-2023
Classification: Class II
Product Type: Drug
Recalling Firm: Pharmacy Plus, Inc. dba Vital Care Compounder
Status: Ongoing
Date Initiated: 10/07/2022
Location: Hattiesburg, MS, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 1 vial

Reason for Recall

Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Product Description

PAPAVERINE/PHENTOLAMINE/PROSTAGLANDIN INJ 150MG/5MG/10MCG/VIAL SOLUTION, 5 ML vial, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402

Distribution Pattern

AL, LA, MS, and TN

Other Recalls by Pharmacy Plus, Inc. dba Vital Care Compounder

Class II: Risk 04/13/2023

Lack of assurance of sterility.
Class II: Risk 10/07/2022

Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Class II: Risk 10/07/2022

Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Class II: Risk 10/07/2022

Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Class II: Risk 10/07/2022

Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

View all recalls by Pharmacy Plus, Inc. dba Vital Care Compounder →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.